Filing Details

Accession Number:
0001547522-16-000257
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-07-12 12:32:01
Reporting Period:
2016-07-08
Filing Date:
2016-07-12
Accepted Time:
2016-07-12 12:32:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
811641 Immucell Corp ICCC In Vitro & In Vivo Diagnostic Substances (2835) 010382980
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1136546 H Joseph Crabb C/O Immucell Corporation
56 Evergreen Drive
Portland ME 04103
Vp & Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.10 Per Share Disposition 2016-07-08 341 $6.53 106,705 No 4 S Direct
Common Stock, Par Value $0.10 Per Share Disposition 2016-07-08 400 $6.50 106,305 No 4 S Direct
Common Stock, Par Value $0.10 Per Share Disposition 2016-07-08 100 $6.51 106,205 No 4 S Direct
Common Stock, Par Value $0.10 Per Share Disposition 2016-07-08 500 $6.55 105,705 No 4 S Direct
Common Stock, Par Value $0.10 Per Share Disposition 2016-07-08 394 $6.59 105,311 No 4 S Direct
Common Stock, Par Value $0.10 Per Share Disposition 2016-07-08 200 $6.60 105,111 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transactions reported herein have been effectuated pursuant to a plan implemented by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.